We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Webinars and Online Events

The Next Step in Evolution of Real-Time Live-Cell Analysis content piece image
Webinar

The Next Step in Evolution of Real-Time Live-Cell Analysis

On-Demand
Combining both real-time live-cell imaging with biosensor-based impedance measurements is now possible for the first time, providing a multi-parametric, information-rich cellular analysis.
The Landscape of Cancer Research 2022 content piece image
Online Event

The Landscape of Cancer Research 2022

On-Demand
Returning for a second year, this online event will provide researchers with a unique opportunity to hear about the advances taking place within cancer research. We will bring together a broad cross-section of experts to share their work in areas such as omics, immunology, drug discovery and cell science.
Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring content piece image
Webinar

Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring

On-Demand
In this webinar you will learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology.
Applying a Closed, Modular, Semi-Automated System to CAR T Cell Therapy Manufacturing content piece image
Webinar

Applying a Closed, Modular, Semi-Automated System to CAR T Cell Therapy Manufacturing

On-Demand
Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the market.
A Successful Journey to Cell Therapy Manufacturing: From Research and Development to Lot-Release content piece image
Webinar

A Successful Journey to Cell Therapy Manufacturing: From Research and Development to Lot-Release

On-Demand
Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.
Harnessing the Metabolism of Oncogenic Signaling for More Effective Anticancer Therapy content piece image
Webinar

Harnessing the Metabolism of Oncogenic Signaling for More Effective Anticancer Therapy

On-Demand
In this webinar, Dr George Poulogiannis from The Institute of Cancer Research, will discuss the relationship between oncogenic signaling and metabolic rewiring and explore cutting-edge technologies that can be used to track metabolism.
Development of a Sensitive SWATH™ MS Workflow To Advance the Characterization of CAR T-Cell Therapies content piece image
Webinar

Development of a Sensitive SWATH™ MS Workflow To Advance the Characterization of CAR T-Cell Therapies

On-Demand
CAR T-cell therapies are emerging anti-cancer treatments, whereby the patient’s immune cells are engineered to express chimeric antigen receptors (CARs) on their surface. Wider adoption of this therapeutic modality would benefit from innovative technologies that can improve the characterization of raw material quality attributes (MQA) and final product quality attributes (PQA).
Advertisement